Enterprise Ireland11.10.21
United States healthcare provider Northwell Health has announced a strategic agreement with Enterprise Ireland, the Irish State agency that partners with Irish businesses to develop Ireland's international trade and innovation.
“Innovation in medical technology solutions is critical to promoting a healthier society. As industry leaders, Northwell Health understands that this large-scale impact is centered around the care an individual receives - and Irish companies are primed for ensuring that patients receive the best care possible,” said Tom Cusack, head of International Sales and Partnering at Enterprise Ireland, “This alliance will facilitate further integration and opportunities for Irish companies within the healthcare industry in the United States.”
The new strategic agreement builds on an earlier alliance with Enterprise Ireland which saw Northwell Health engage with Irish medtech companies and provide access to clinicians and key decision-makers across their extensive healthcare network, develop and commercialize new medical technologies, and collaborate in joint ventures.
“Through our agreement with Enterprise Ireland, we are able to pursue relationships with innovative companies whose technologies bring benefits to our patients while improving the efficiency and effectiveness of our care delivery,” stated Elaine Brennan, executive director of Global Strategic Partnerships at Northwell Health. “With these collaborations we hope to commercialize medical technologies to benefit patients around the globe. The strategic alliance with Enterprise Ireland is one of many overseas relationships in which Northwell is engaging as it takes a global view to identifying the most innovative solutions and partnerships.”
The signing will occur as part of Ireland’s trade visit to New York led by Minister for Trade Promotion, Robert Troy, which overlaps with Enterprise Ireland’s annual Med in Ireland conference. As Ireland’s largest medical technologies event, Med in Ireland brings together over 500 delegates from around the world to showcase Ireland’s medtech industry and connect Irish medtech innovators with international healthcare providers.
“Med in Ireland is a hugely important event for international healthcare providers and manufactures to engage with Ireland’s medtech industry. The sector is hugely important for the Irish economy, employing 45,000 people. It is also making a major contribution to international healthcare, responding to Covid-19 and the transformation of healthcare,” announced Troy. “Years of Government and industry investment has fueled the resilient response to the pandemic and created a culture of innovation and expertise in Ireland.”
This year’s theme ‘Medtech’s Big Moment’, will focus on the major industry shifts in the last 20 months that are shaping the post-pandemic healthcare world. This includes the move to preventative care, the role of digitalization in the shift to healthcare outside of hospital settings and the resulting increased need for cybersecurity measures, the emergence of technologies that reduce environmental impact and improve competitiveness, and the development of new distribution and inventory management models to address supply chain weaknesses.
“Innovation in medical technology solutions is critical to promoting a healthier society. As industry leaders, Northwell Health understands that this large-scale impact is centered around the care an individual receives - and Irish companies are primed for ensuring that patients receive the best care possible,” said Tom Cusack, head of International Sales and Partnering at Enterprise Ireland, “This alliance will facilitate further integration and opportunities for Irish companies within the healthcare industry in the United States.”
The new strategic agreement builds on an earlier alliance with Enterprise Ireland which saw Northwell Health engage with Irish medtech companies and provide access to clinicians and key decision-makers across their extensive healthcare network, develop and commercialize new medical technologies, and collaborate in joint ventures.
“Through our agreement with Enterprise Ireland, we are able to pursue relationships with innovative companies whose technologies bring benefits to our patients while improving the efficiency and effectiveness of our care delivery,” stated Elaine Brennan, executive director of Global Strategic Partnerships at Northwell Health. “With these collaborations we hope to commercialize medical technologies to benefit patients around the globe. The strategic alliance with Enterprise Ireland is one of many overseas relationships in which Northwell is engaging as it takes a global view to identifying the most innovative solutions and partnerships.”
The signing will occur as part of Ireland’s trade visit to New York led by Minister for Trade Promotion, Robert Troy, which overlaps with Enterprise Ireland’s annual Med in Ireland conference. As Ireland’s largest medical technologies event, Med in Ireland brings together over 500 delegates from around the world to showcase Ireland’s medtech industry and connect Irish medtech innovators with international healthcare providers.
“Med in Ireland is a hugely important event for international healthcare providers and manufactures to engage with Ireland’s medtech industry. The sector is hugely important for the Irish economy, employing 45,000 people. It is also making a major contribution to international healthcare, responding to Covid-19 and the transformation of healthcare,” announced Troy. “Years of Government and industry investment has fueled the resilient response to the pandemic and created a culture of innovation and expertise in Ireland.”
This year’s theme ‘Medtech’s Big Moment’, will focus on the major industry shifts in the last 20 months that are shaping the post-pandemic healthcare world. This includes the move to preventative care, the role of digitalization in the shift to healthcare outside of hospital settings and the resulting increased need for cybersecurity measures, the emergence of technologies that reduce environmental impact and improve competitiveness, and the development of new distribution and inventory management models to address supply chain weaknesses.